Retraction: Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study (Journal of Digestive Diseases, (2012), 13, 3, 10.1111/j.1751-2980.2011.00571.x);Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study

Journal of Digestive Diseases

Volumn 13, Issue 3, 2012, Pages 153-160

  Zhou, Yong Jian ^a   Li, Yu Yuan ^a   Nie, Yu Qiang ^a   Huang, Chun Ming ^a   Cao, Chuang Yu ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Epidemiology; Incidence; Metabolic syndrome; Natural history; Nonalcoholic fatty liver disease

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84863148823     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.13112     Document Type: Erratum

References (34)

1. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-61.
2. Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009; 13: 511-31.
3. Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia-Pacific Working Party for NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-7.
4. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-10.
5. Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010; 103: 71-83.
6. Shifflet A, Wu GY. Non-alcoholic steatohepatitis: an overview. J Formos Med Assoc 2009; 108: 4-12.
7. Zhou YJ, Li YY, Nie YQ etal. Prevalence of fatty liver disease and its risk factors in the population of south China. World J Gastroenterol 2007; 13: 6419-24.
8. Fan JG, Zhu J, Li XJ etal. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005; 20: 1825-32.
9. Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases. Chin J Hepatol 2006; 14: 161-3 (in Chinese).
10. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007; 6: 572-8.
11. Einhorn D, Reaven GM, Cobin RH etal. AACE position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-52.
12. Graif M, Yanuka M, Baraz M etal. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-24.
13. Hamaguchi M, Kojima T, Itoh Y etal. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15.
14. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-7.
15. Bu XM. 2000 census of Guangdong Province. In: National Bureau of Statistics, ed. Data of the Fifth Chinese Census (2000), 1st edn. Beijing: Press of Chinese Statistics, 2001; 1-45 (in Chinese).
16. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85.
17. Hamaguchi M, Kojima T, Takeda N etal. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-8.
18. Suzuki A, Angulo P, Lymp J etal. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 2005; 41: 64-71.
19. Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD) - two decades later: are we smarter about its natural history? Am J Gastroenterol 2003; 98: 1915-7.
20. Fan JG, Jia JD, Li YM etal; Chinese Association for the Study of Liver Disease. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 2011; 12: 38-44.
21. Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 2011; 12: 10-16.
22. Adams LA, Sanderson S, Lindor KD etal. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-8.
23. Lindor KD, Kowdley KV, Heathcote EJ etal. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39: 770-8.
24. Fassio E, Alvarez E, Domínguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004; 40: 820-6.
25. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-7.
26. Ekstedt M, Franzén LE, Mathiesen UL etal. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-73.
27. Yerian L. Histopathological evaluation of fatty and alcoholic liver diseases. J Dig Dis 2011; 12: 17-24.
28. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
29. Rafiq N, Bai C, Fang Y etal. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-8.
30. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42: 320-30.
31. Lu H, Zeng L, Liang B, Shu X, Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res 2009; 40: 571-5.
32. Zhou YJ, Li YY, Nie YQ etal. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol 2010; 25: 772-7.
33. Hui Y, Yu-Yuan L, Yu-Qiang N etal. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int 2008; 28: 385-92.
34. Hai-Xia C, Jian-Gao F. Editorial: fatty liver disease: a growing public health problem worldwide. J Dig Dis 2011; 12: 1-2.